Patrik Ringblom

Director/Miembro de la Junta en SPECTRACURE AB .

62 años

Health Technology

Electronic Technology

Consumer Services

Perfil

Patrik Ringblom is currently an Independent Director at SpectraCure AB since 2025 and Head-Strategy & US Lead at Lakefront Biotherapeutics since 2023.
Formerly, Mr. Ringblom was VP-Rare Disease Novel Therapeutics & Alliance at Johnson & Johnson from 2022 to 2023.
Mr. Ringblom completed an MBA at Handelshögskolan i Göteborg.

Cargos activos de Patrik Ringblom

Empresas	Cargo	Inicio
LAKEFRONT BIOTHERAPEUTICS NV	Corporate Officer/Principal	01/10/2023
SPECTRACURE AB	Director/Miembro de la Junta	01/01/2025

Todos los cargos activos de Patrik Ringblom

Antiguos cargos conocidos de Patrik Ringblom.

Empresas	Cargo	Fin
JOHNSON & JOHNSON	Corporate Officer/Principal	01/10/2023

Ver el detalle de la experiencia de Patrik Ringblom.

Formación de Patrik Ringblom.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Patrik Ringblom.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
SpectraCure AB SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment	Electronic Technology
Handelshögskolan i Göteborg Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services